TDSPHARM's Largest Shareholder Cheoljun Kim and Special Relations Increase Stake by 0.10% via Open Market Purchases
The largest shareholder of TDSPHARM, Cheoljun Kim, along with five special relations, acquired an additional 5,422 shares through open market purchases on June 15, 2026.
This increased their combined stake from 46.25% to 46.35%, a 0.10 percentage point rise, signaling management confidence through a small-scale insider buying move.
All purchase funds were sourced from personal savings and labor income, with no external borrowing or contracts, indicating low financial risk.
[AI Summary]TDSPHARM's largest shareholder's minor increase in stake is a positive signal for short-term stock sentiment, but the change is too small to materially affect shareholder value. It reflects stable control intentions without capital allocation for growth, resulting in a neutral overall impact.